resynchronization therapy

resynchronization therapy

(re?sing?kro-ni-za'shon) [ re- + synchronize]
The use of left and right ventricular pacemaking in patients with congestive heart failure and bundle branch block to restore the normal timing of ventricular depolarization. Resynchronization reduces symptoms of heart failure.
Synonym: cardiac resynchronization therapy
Mentioned in ?
References in periodicals archive ?
The company said Edora HF-T QP is an MR conditional quadripolar (QP) cardiac resynchronization therapy pacemaker (CRT-P) with MRI AutoDetect technology.
Objective: To determine the success rate of cardiac resynchronization therapy and defibrillator implantation in heart failure patients.
Medtronic s cardiac resynchronization therapy pacemakers and defibrillators can delay the occurrence of heart failure-related urgent care visits for people who meet these new criteria, said Christy Foreman, director of the Office of Device Evaluation in the FDA s Center for Devices and Radiological Health.
Cardiac resynchronization therapy became the standard treatment for patients with heart failure refractory to standard medication and delay in ventricular conduction.
DALLAS -- Cardiac resynchronization therapy demonstrated a robust cost-effectiveness of $18,275 per quality-adjusted life-year gained in an analysis from the landmark REVERSE trial.
Cardiac resynchronization therapy (CRT) is a very effective therapy for the group of patients with symptomatic heart failure (HF), low ejection fraction and a broad QRS complex.
Cardiac resynchronization therapy (CRT) is an innovative therapy that can relieve chronic heart failure symptoms by improving the coordination of the heart's contractions using a specialized pacemaker.
The overall benefit observed from resynchronization therapy was driven by a 41 percent reduction in heart failure.
Major cardiac resynchronization therapy trials typically exclude patients with atrial fibrillation.
The patient, who met clinical guidelines for cardiac resynchronization therapy (CRT), was a 69 year old male with ischemic heart disease, class 3 heart failure and prolonged QRS who had a previously implanted St Jude Medical dual chamber ICD (in 2008).
Cardiac resynchronization therapy is known to reduce the amount of functional mitral regurgitation in patients with left ventricular systolic failure although some may not respond to treatment with cardiac resynchronization therapy.
The study showed a 29pct reduction in heart failure and mortality risk in patients who received an implanted cardiac resynchronization therapy device with defibrillator (CRT-D) compared to patients who received only an implanted cardiac defibrillator (ICD-only).